Spectral AI (MDAI) Competitors

Spectral AI logo
$1.35 +0.00 (+0.22%)
As of 09:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

MDAI vs. STIM, INGN, KRMD, FOCL, and OWLT

Should you buy Spectral AI stock or one of its competitors? Spectral AI's main competitors and comparable companies include Neuronetics (STIM), Inogen (INGN), KORU Medical Systems (KRMD), FocalTherics (FOCL), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Spectral AI compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Neuronetics has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market.

Spectral AI has lower revenue, but higher earnings than Neuronetics. Spectral AI is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neuronetics$149.16M0.67-$39M-$0.33N/A
Spectral AI$19.65M2.20-$7.57M-$0.33N/A

In the previous week, Neuronetics had 12 more articles in the media than Spectral AI. MarketBeat recorded 16 mentions for Neuronetics and 4 mentions for Spectral AI. Neuronetics' average media sentiment score of 0.25 beat Spectral AI's score of -0.28 indicating that Neuronetics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neuronetics
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Neuronetics has a net margin of -14.45% compared to Spectral AI's net margin of -74.56%. Spectral AI's return on equity of 0.00% beat Neuronetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Neuronetics-14.45% -102.23% -16.83%
Spectral AI -74.56%N/A -79.07%

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Neuronetics currently has a consensus price target of $5.00, suggesting a potential upside of 290.63%. Spectral AI has a consensus price target of $4.00, suggesting a potential upside of 197.40%. Given Neuronetics' higher possible upside, analysts clearly believe Neuronetics is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neuronetics
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Neuronetics beats Spectral AI on 8 of the 14 factors compared between the two stocks.

How does Spectral AI compare to Inogen?

Spectral AI (NASDAQ:MDAI) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Inogen has a net margin of -10.46% compared to Spectral AI's net margin of -74.56%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-74.56% N/A -79.07%
Inogen -10.46%-19.29%-12.02%

Spectral AI presently has a consensus price target of $4.00, suggesting a potential upside of 197.40%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Spectral AI has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$19.65M2.20-$7.57M-$0.33N/A
Inogen$348.67M0.42-$22.75M-$1.31N/A

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 2.5% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Spectral AI has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Inogen has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

In the previous week, Spectral AI had 3 more articles in the media than Inogen. MarketBeat recorded 4 mentions for Spectral AI and 1 mentions for Inogen. Inogen's average media sentiment score of 0.74 beat Spectral AI's score of -0.28 indicating that Inogen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inogen
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Spectral AI beats Inogen on 9 of the 15 factors compared between the two stocks.

How does Spectral AI compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

KORU Medical Systems has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market.

In the previous week, KORU Medical Systems had 2 more articles in the media than Spectral AI. MarketBeat recorded 6 mentions for KORU Medical Systems and 4 mentions for Spectral AI. KORU Medical Systems' average media sentiment score of 0.65 beat Spectral AI's score of -0.28 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems currently has a consensus price target of $6.50, indicating a potential upside of 86.25%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 197.40%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

KORU Medical Systems has higher revenue and earnings than Spectral AI. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.68-$2.64M-$0.02N/A
Spectral AI$19.65M2.20-$7.57M-$0.33N/A

KORU Medical Systems has a net margin of -1.78% compared to Spectral AI's net margin of -74.56%. Spectral AI's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-1.78% -4.62% -2.90%
Spectral AI -74.56%N/A -79.07%

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 13.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

KORU Medical Systems beats Spectral AI on 10 of the 16 factors compared between the two stocks.

How does Spectral AI compare to FocalTherics?

Spectral AI (NASDAQ:MDAI) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

FocalTherics has a net margin of -59.77% compared to Spectral AI's net margin of -74.56%. Spectral AI's return on equity of 0.00% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-74.56% N/A -79.07%
FocalTherics -59.77%-223.32%-41.32%

Spectral AI currently has a consensus target price of $4.00, indicating a potential upside of 197.40%. FocalTherics has a consensus target price of $9.67, indicating a potential upside of 240.38%. Given FocalTherics' higher possible upside, analysts plainly believe FocalTherics is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by company insiders. Comparatively, 10.1% of FocalTherics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Spectral AI has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market.

Spectral AI has higher earnings, but lower revenue than FocalTherics. Spectral AI is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$19.65M2.20-$7.57M-$0.33N/A
FocalTherics$70.53M1.51-$29.25M-$0.98N/A

In the previous week, Spectral AI had 2 more articles in the media than FocalTherics. MarketBeat recorded 4 mentions for Spectral AI and 2 mentions for FocalTherics. FocalTherics' average media sentiment score of 0.66 beat Spectral AI's score of -0.28 indicating that FocalTherics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
FocalTherics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Spectral AI beats FocalTherics on 9 of the 14 factors compared between the two stocks.

How does Spectral AI compare to Owlet?

Spectral AI (NASDAQ:MDAI) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Spectral AI presently has a consensus target price of $4.00, suggesting a potential upside of 197.40%. Owlet has a consensus target price of $12.00, suggesting a potential upside of 269.80%. Given Owlet's higher probable upside, analysts plainly believe Owlet is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by insiders. Comparatively, 36.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Spectral AI has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Owlet has a beta of 2.17, indicating that its stock price is 117% more volatile than the broader market.

In the previous week, Owlet had 10 more articles in the media than Spectral AI. MarketBeat recorded 14 mentions for Owlet and 4 mentions for Spectral AI. Owlet's average media sentiment score of 0.40 beat Spectral AI's score of -0.28 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Owlet has a net margin of -11.11% compared to Spectral AI's net margin of -74.56%. Spectral AI's return on equity of 0.00% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-74.56% N/A -79.07%
Owlet -11.11%-53.97%-13.77%

Spectral AI has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$19.65M2.20-$7.57M-$0.33N/A
Owlet$105.70M0.92-$39.68M-$0.68N/A

Summary

Owlet beats Spectral AI on 10 of the 16 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AIHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$43.33M$5.99B$7.83B$11.74B
Dividend YieldN/A1.68%2.47%4.47%
P/E Ratio-4.0838.0633.9728.44
Price / Sales2.215.398.495.70
Price / CashN/A23.6221.0121.90
Price / Book-7.094.174.453.72
Net Income-$7.57M$143.92M$3.52B$393.10M
7 Day Performance-4.40%-5.44%-5.94%-5.77%
1 Month Performance-10.73%-3.64%-4.58%-7.14%
1 Year Performance-5.73%-0.05%-1.95%-7.47%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
1.6762 of 5 stars
$1.35
+0.2%
$4.00
+196.7%
-6.6%$43.33M$19.65MN/A65
STIM
Neuronetics
3.7583 of 5 stars
$2.01
-7.8%
$5.00
+148.8%
-22.4%$169.45M$149.16MN/A658
INGN
Inogen
1.0679 of 5 stars
$6.00
-1.8%
N/A-15.4%$162.28M$348.67MN/A753
KRMD
KORU Medical Systems
3.861 of 5 stars
$3.16
-2.2%
$7.00
+121.5%
-22.3%$148.36M$41.13MN/A73
FOCL
FocalTherics
2.3703 of 5 stars
$3.50
-0.6%
$9.67
+176.2%
N/A$132.10M$70.53MN/A230

Related Companies and Tools


This page (NASDAQ:MDAI) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners